SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Kabra Drugs Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524322 INE323K01017 10.9633096 Not Listed 0 70.91 16.52 1.81 10
Quarters :
ParticularsDec 2025(Rs.Cr)Sep 2025(Rs.Cr)Jun 2025(Rs.Cr)
Gross Sales30.4219.767.15
Other Operating Income0.000.000.00
Other Income 0.180.180.02
Total Income30.6019.947.17
Total Expenditure 27.9917.737.66
PBIDT2.622.22-0.50
Interest 0.000.000.00
PBDT2.612.22-0.50
Depreciation0.010.010.00
Tax0.030.370.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.010.000.00
Reported Profit After Tax2.571.84-0.50
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item2.571.84-0.50
    
EPS (Unit Curr.)1.080.77-0.21
EPS (Adj) (Unit Curr.)1.080.77-0.21
Calculated EPS (Unit Curr.)1.080.77-0.21
Calculated EPS (Adj) (Unit Curr.)1.080.77-0.21
Calculated EPS (Ann.) (Unit Curr.)4.333.10-0.84
Calculated EPS (Adj) (Ann.) (Unit Curr.)4.333.10-0.84
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity23.7123.7123.71
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)8.6111.23-6.99
PBDTM(%)8.5811.23-6.99
PATM(%)8.459.31-6.99